针对骨相关疾病中的铁亡:事实和前景
Haoran Chen1,2, Zhongyu Han2, Yi Wang1
1Department of Orthopaedics, Chengdu Xinhua Hospital, Chengdu, 610000, People's Republic of China.
Journal of inflammation research
|October 24, 2023
概括
铁,一种依赖于铁的细胞死亡,越来越多地与骨质疏松症和骨关节炎等骨疾病有关. 了解它的机制为治疗骨疾病提供了新的治疗途径.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 铁亡是一种独特的受调细胞死亡形式,其特征是依赖铁的脂质过氧化.
- 它不同于亡,自和热,具有独特的线粒体形态变化.
- 铁死在各种生理和病理过程中起作用.
研究的目的:
- 审查有关骨相关疾病中的铁亡的最新研究.
- 要总结铁灭的调节机制.
- 讨论铁死在骨疾病中的作用和治疗潜力.
主要方法:
- 关于铁亡和骨疾病的最新研究的文献综述.
- 综合有关铁亡调节通路的信息.
- 在骨质疏松症,骨关节炎,类风湿性关节炎和骨质肉瘤中对铁质的参与进行了分析.
主要成果:
- 铁亡与主要骨疾病的发病有关.
- 确定了铁亡的特定调节机制.
- 铁亡具有作为治疗骨疾病的治疗点的潜力.
结论:
- 铁亡是骨疾病发展的一个重要因素.
- 向铁亡可能为骨疾病提供新的治疗策略.
- 对铁亡机制的进一步研究对于临床应用至关重要.
更多相关视频
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
943
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.7K
相关概念视频
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
